Summary
In a randomized controlled clinical trial, the efficacy and safety of two low molecular weight heparin (LMWH) fractions in the prophylaxis of deep vein thrombosis (DVT) were assessed. One hundred twenty-six patients undergoing major abdominal surgery received alternatively 2,500 APTT units b.i.d. of two LMWH fractions or 5,000 APTT units b.i.d. of an unfractionated sodium mucosal heparin (UFH). LMWH 2 differed from LMWH 1 by presenting a lower mean molecular weight and a higher anti-Xa/APTT ratio in vitro. Patients were randomly allocated to the three groups, and the development of DVT was studied with the125I-fibrinogen uptake test (RFUT).
The study was interrupted and the code broken prematurely because of otherwise unexplainable bleeding events.
While no thrombosis and no severe bleeding were detected in the UFH group, three (7%) RFUT-positive DVT and two (5%) hemorrhagic complications occurred in the LMWH 1 group. No thrombosis and nine (22%) cases of severe bleeding were observed in the LMWH 2 group. Thus, the latter group differed significantly from the control group with regard to subjective and objective criteria for postoperative bleeding.
Although these results do not allow general conclusions as to the value of LMWH fractions in the prevention of DVT, they indicate that these preparations just as ordinary heparin have a limited therapeutic range.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Reference
Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook G, Thomas DP (1979) Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haematol 41:573–583
Carter CJ, Kelton JG, Hirsh J, Cerkus A, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 59:1239–1245
Clayton JK, Anderson JA, Mc Nicol GP (1976) Preoperative prediction of postoperative deep vein thrombosis. Br Med J 2:910–912
Holmer E, Lindahl U, Bäckström G, Thunberg L, Sandberg H, Söderström G, Andersson L-O (1980) Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 18:861–869
Holmer E, Kurachi K, Söderström G (1981) The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem J 193:395–400
Johnson EA, Kirkwood TBL, Stirling Y, Perez-Requejo JL, Ingram GIC, Banham DR, Brozovic M (1976) Four heparin preparations: anti Xa-potentiating effect of heparin after subcutaneous injection. Thromb Haemostas 35:586–591
Kakkar VV (1977) Fibrinogen uptake test detection of deep vein thrombosis — a review of current practice. Semin Nucl Med 7:229–244
Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J (1982) Low molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 284:375–379
Kelton JG, Hirsh J (1980) Bleeding associated with anti-thrombotic therapy. Semin Hematol 17:259–291
Mühe E (1983) Physiotherapy in the prophylaxis of venous thrombosis. In: van de Loo J, Prentice CRM, Beller FK (eds) The thromboembolic disorders. Schattauer, Stuttgart New York, pp 281–294
Oosta GM, Gardner WT, Beeler DL, Rosenberg RD (1981) Multiple functional domains of the heparin molecule. Proc Natl Acad Sci USA 78:829–833
Rákóczi I, Chamone D, Verstraete M, Collen D (1980) The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecologic patients. Surg Gynecol Obstet 151:225–231
Sachs L (1978) Angewandte Statistik. Springer, Berlin Heidelberg New York
Salzmann EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L (1980) Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64–73
Schmitz-Huebner U, Balleisen L, Asbeck F, van de Loo J (1981) In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions. Thromb Haemostas 46:612–616
Thomas DP, Merton RE (1982) A low molecular weight heparin compared with unfractionated heparin. Thromb Res 28:343–350
Walker AM, Jick H (1980) Predictors of bleeding during heparin therapy. J Am Med Assoc 244:1209–1212
Author information
Authors and Affiliations
Additional information
Supported by a grant (Schm 345/4-2) from the Deutsche Forschungsgemeinschaft
Rights and permissions
About this article
Cite this article
Schmitz-Huebner, U., Bünte, H., Freise, G. et al. Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis. Klin Wochenschr 62, 349–353 (1984). https://doi.org/10.1007/BF01716253
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716253